Investor Relations

Investor Relations

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders.

 

Recent Releases

Apr 21, 2014
Clinical Trial Results Indicate Acthar May Significantly Reduce Proteinuria in Patients with Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy

Apr 17, 2014
Questcor Partners with National Kidney Foundation as National Sponsor of Kidney Walk

Apr 7, 2014
Questcor Announces Quarterly Cash Dividend

View all releases »

Events & Presentations

Apr 7, 2014 at 8:30 AM ET
Conference Call to discuss Acquisition

Feb 25, 2014 at 4:30 PM ET
Q4 2013 Questcor Pharmaceuticals, Inc. Earnings Conference

View all events & presentations »

Investor Presentation
April 2014
Mallinckrodt-Questcor Investor Presentation
Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
Questcor Pharmaceuticals, Inc.
Price: 77.53
Change: + 0.58
Day High: 77.66
Day Low: 76.49
Volume: 519,300
Delayed at least 20 minutes.
Provided by eSignal.

 

Transfer Agent

Computershare Trust Co., Inc.
Phone 303-262-0600

Corporate Counsel

Stradling Yocca Carlson & Rauth
Newport Beach, CA

Independent Accountants

BDO USA, LLP

Questcor Investor and
Media Relations:

714-497-4899